Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 50
2021 65
2022 11
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 33952621

106 results

Results by year

Filters applied: . Clear all
Page 1
Managing drug shortages during a pandemic: tocilizumab and COVID-19.
Verma AA, Pai M, Saha S, Bean S, Fralick M, Gibson JL, Greenberg RA, Kwan JL, Lapointe-Shaw L, Tang T, Morris AM, Razak F. Verma AA, et al. CMAJ. 2021 May 25;193(21):E771-E776. doi: 10.1503/cmaj.210531. Epub 2021 May 5. CMAJ. 2021. PMID: 33952621 Free PMC article. No abstract available.
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.
Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, Machado FR, Lopes RD, Berwanger O, Azevedo LCP, Avezum Á, Lisboa TC, Rojas SSO, Coelho JC, Leite RT, Carvalho JC, Andrade LEC, Sandes AF, Pintão MCT, Castro CG Jr, Santos SV, de Almeida TML, Costa AN, Gebara OCE, de Freitas FGR, Pacheco ES, Machado DJB, Martin J, Conceição FG, Siqueira SRR, Damiani LP, Ishihara LM, Schneider D, de Souza D, Cavalcanti AB, Scheinberg P; Coalition covid-19 Brazil VI Investigators. Veiga VC, et al. BMJ. 2021 Jan 20;372:n84. doi: 10.1136/bmj.n84. BMJ. 2021. PMID: 33472855 Free PMC article. Clinical Trial.
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, Merhametsiz O, Yadigar S, Atan Ucar Z, Ucar AR, Demir ME, Mese M, Akin EB, Garayeva N, Safak S, Oto OA, Yazici H, Turkmen A. Demir E, et al. Transpl Infect Dis. 2020 Oct;22(5):e13371. doi: 10.1111/tid.13371. Epub 2020 Jul 13. Transpl Infect Dis. 2020. PMID: 32657540 Free PMC article.
Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis.
Urbina T, Lavillegrand JR, Garnier M, Mekinian A, Pacanowski J, Mario N, Dumas G, Hariri G, Pilon A, Darrivère L, Fartoukh M, Guidet B, Maury E, Leblanc J, Chantran Y, Fain O, Lacombe K, Voiriot G, Ait-Oufella H. Urbina T, et al. Innate Immun. 2022 Jan;28(1):3-10. doi: 10.1177/17534259211064602. Epub 2022 Jan 28. Innate Immun. 2022. PMID: 35089113 Free PMC article.
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab.
Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L. Lauterio A, et al. Transpl Infect Dis. 2020 Oct;22(5):e13334. doi: 10.1111/tid.13334. Epub 2020 Jun 2. Transpl Infect Dis. 2020. PMID: 32449235 Free PMC article.
No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study.
Burlacu R, London J, Fleury A, Sené T, Diallo A, Meyssonnier V, Zeller V, Galland J, Huscenot T, Rubenstein E, Trouiller P, Amathieu R, Kutter J, Blondeel D, Lejour G, Mouly S, Lidove O, Wladimir M, Sène D. Burlacu R, et al. Medicine (Baltimore). 2021 May 28;100(21):e26023. doi: 10.1097/MD.0000000000026023. Medicine (Baltimore). 2021. PMID: 34032722 Free PMC article.
106 results